PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425019
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425019
Tissue Sectioning Market size was valued at USD 710.41 Million in 2022, expanding at a CAGR of 6.5% from 2023 to 2030.
The technique of sectioning involves slicing tissue into small pieces. Before tissue is sectioned, it is usually immersed in paraffin or optimal cutting temperature (OCT). In pathology and histology, sectioning paraffin-embedded tissue is a common procedure.
Tissue Sectioning Market- Market Dynamics
Rising demand for histopathology tests and prevalence of cancer to propel market demand
Key factors driving demand for histopathology testing is the rising prevalence of chronic diseases and cancers, as a tissue pathology examination is critical to the diagnosis of a malignant tumor. One of the main causes of death in the world today is thought to be cancer. Pathologists can identify the kind, stage, and extent of cancerous invasion of healthy tissues by analyzing biopsy samples. As a result, histopathology, tissue sectioning, and staining devices are being used more frequently, which is driving the market's expansion. These factors are expected to boost the demand for tissue sectioning market.
Growth in customized treatments and diagnostics is anticipated to accelerate market expansion. Treatment for cancer is increasingly centered around personalized medicine, which is also finding its way into other domains. This is a rapidly developing method of tailoring care according on each patient's unique genetic composition. The science of customized medicine is reliant on the use of human tissue for the creation of novel tests, which has resulted in a rise in demand for its utilization. One of the main factors driving the market is the increase in cancer screening awareness campaigns run by groups like the U.S. Preventive Services Task Force (USPSTF), the World Health Organization (WHO), the Centres for Disease Control and Prevention (CDC), and the National Cervical Cancer Coalition.
Tissue Sectioning Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2023-2030)
Based on Product segmentation, instruments segment was predicted to show maximum market share in the year 2022, owing to wide range of product categories.
Based on Application segmentation, disease diagnosis segment was the leading segment in 2022, due to high need for diagnosis of cancer diseases.
Based on End-User segmentation, hospitals segment was the leading segment in 2022, mainly due to increasing number of hospital admission cases.
On the basis of region, North America was the leading revenue generator in 2022, owing to advanced healthcare facilities in the U.S.
The Global Tissue Sectioning Market is segmented on the basis of Product, Application, End-User, and Region.
The market is divided into two categories based on Product: instruments, and accessories. The instruments segment dominates the market. The availability of a wide range of products in testing is expected to boost the instruments demand.
The market is divided into two categories based on Application: disease diagnosis and research. The disease diagnosis segment dominates the market and is likely to maintain its dominance during the forecast period. The growing prevalence of pathological disorders and cancer is boosting the segment growth.
The market is divided into three categories based on End-User: hospitals, clinics, and diagnosis laboratories. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. The increased application of biopsy specimens for histopathology is boosting the market growth.
Tissue Sectioning Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period because of the sophisticated healthcare infrastructure, growing governmental and private sector investments in tissue diagnostics, and the widespread use of very modern, completely automated technologies. The rising incidence of cancer in North America raises the need for biopsies to diagnose cancer, which in turn raises the need for tissue sectioning tools.
To keep a competitive edge, market firms collaborate with laboratories. The issue of under processed tissue is anticipated to be resolved by initiatives taken by the major companies for resolving the processing problems encountered by the lab workers. The businesses actively offer specialized histology solutions for FFPE DNA or RNA isolation, which are very useful in the field of research. Sakura Finetek Europe B.V., Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, and Thermo Fisher Scientific are a few of the major industry participants.
In January 2023, Agilent Technologies Inc., partnered with Akoya Biosciences Inc., to develop immunohistochemistry diagnostic solutions.